A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Xie, Tao ^a   d' Ario, Giovanni ^b   Lamb, John R ^a   Martin, Eric ^a   Wang, Kai ^a   Tejpar, Sabine ^c   Delorenzi, Mauro ^b,d   Bosman, Fred T ^d   Roth, Arnaud D ^e   Yan, Pu ^d   Bougel, Stephanie ^d   Di Narzo, Antonio Fabio ^b   Popovici, Vlad ^b   Budinská, Eva ^b   Mao, Mao ^a   Weinrich, Scott L ^a   Rejto, Paul A ^a   Hodgson, J Graeme ^a  

^a PFIZER INC   (United States)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APC GENE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CCND1 GENE; CHROMOSOME 18; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COLORECTAL CANCER; CONTROLLED STUDY; EEF1B2 GENE; EGFR GENE; ERBB2 GENE; GENE AMPLIFICATION; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC GAIN; HNF4A GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MET GENE; MICROSATELLITE INSTABILITY; ONCOGENE; ONCOGENE MYC; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PTK GENE; SMAD4 GENE; SURVIVAL RATE; TP53 GENE; WNK1 GENE;

CHROMOSOMES, HUMAN, PAIR 16; COLORECTAL NEOPLASMS; GENE DOSAGE; GENOME, HUMAN; HUMANS; MICROSATELLITE REPEATS; ONCOGENES;

EID: 84864436663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042001     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. ((2008)) Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians 58:: 71--96.
2. Fearon ER, Vogelstein B, ((1990)) A genetic model for colorectal tumorigenesis. Cell 61:: 759--767.
3. Vogelstein B, Kinzler KW, ((2004)) Cancer genes and the pathways they control. Nat Med 10:: 789--799.
4. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. ((2007)) The genomic landscapes of human breast and colorectal cancers. Science 318:: 1108--1113.
5. Speleman F, Kumps C, Buysse K, Poppe B, Menten B, et al. ((2008)) Copy number alterations and copy number variation in cancer: close encounters of the bad kind. Cytogenet Genome Res 123:: 176--182.
6. Sayagues JM, Fontanillo C, Abad Mdel M, Gonzalez-Gonzalez M, Sarasquete ME, et al. ((2010)) Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays. PLoS ONE 5:: e13752.
7. Ashktorab H, Schaffer AA, Daremipouran M, Smoot DT, Lee E, et al. ((2010)) Distinct genetic alterations in colorectal cancer. PLoS ONE 5:: e8879.
8. Kurashina K, Yamashita Y, Ueno T, Koinuma K, Ohashi J, et al. ((2008)) Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma. Cancer Sci 99:: 1835--1840.
9. Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, et al. ((2002)) Silence of chromosomal amplifications in colon cancer. Cancer Res 62:: 1134--1138.
10. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, et al. ((1996)) Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:: 234--245.
11. Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, et al. ((2004)) Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64:: 4817--4825.
12. Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, et al. ((2004)) High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25:: 1345--1357.
13. Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, et al. ((2009)) Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes Chromosomes Cancer 48:: 1002--1017.
14. Ji H, ((2006)) Molecular Inversion Probe Analysis of Gene Copy Alterations Reveals Distinct Categories of Colorectal Carcinoma. Cancer Research 66:: 7910--7919.
15. Bartos JD, Gaile DP, McQuaid DE, Conroy JM, Darbary H, et al. ((2007)) aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL. Mutat Res 615:: 1--11.
16. Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, et al. ((2009)) Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes Chromosomes Cancer 48:: 953--962.
17. Brosens RP, Haan JC, Carvalho B, Rustenburg F, Grabsch H, et al. ((2010)) Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J Pathol 221:: 411--424.
18. Martin ES, Tonon G, Sinha R, Xiao Y, Feng B, et al. ((2007)) Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 67:: 10736--10743.
19. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, et al. ((2009)) Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer. Proceedings of the National Academy of Sciences 106:: 7131--7136.
20. Postma C, Koopman M, Buffart TE, Eijk PP, Carvalho B, et al. ((2009)) DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Annals of Oncology 20:: 1048--1056.
21. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, et al. ((2006)) The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45:: 31--41.
22. Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A, Kuiper RP, ((2008)) Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms. Cytogenet Genome Res 123:: 188--194.
23. Nakao M, Kawauchi S, Furuya T, Uchiyama T, Adachi J, et al. ((2009)) Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles. Cancer Genet Cytogenet 188:: 70--76.
24. Poulogiannis G, Ichimura K, Hamoudi RA, Luo F, Leung SY, et al. ((2010)) Prognostic relevance of DNA copy number changes in colorectal cancer. J Pathol 220:: 338--347.
25. Van Cutsem E, Labianca R, Bodoky G, Barone C, Aranda E, et al. ((2009)) Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol 27:: 3117--3125.
26. Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, et al. ((2012)) Identification of a Poor-Prognosis BRAF-Mutant-Like Population of Patients With Colon Cancer. J Clin Oncol.
27. Olshen AB, Venkatraman ES, Lucito R, Wigler M, ((2004)) Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:: 557--572.
28. Diskin SJ, Eck T, Greshock J, Mosse YP, Naylor T, et al. ((2006)) STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Res 16:: 1149--1158.
29. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, et al. ((2011)) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12:: R41.
30. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, et al. ((2011)) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27:: 1739--1740.
31. Xie T, Zhang C, Zhang B, Molony C, Oudes A, et al. ((2010)) A survey of cancer cell lines reveals highly structured and hierarchical relationships within and between DNA and mRNA that may be the result of selection. OMICS 14:: 91--97.
32. Camps J, Armengol G, del Rey J, Lozano JJ, Vauhkonen H, et al. ((2006)) Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27:: 419--428.
33. Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, et al. ((2009)) Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene 28:: 2569--2580.
34. Lamb JR, Zhang C, Xie T, Wang K, Zhang B, et al. ((2011)) Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS ONE 6:: e20090.
35. Wierzbicki PM, Adrych K, Kartanowicz D, Dobrowolski S, Stanislawowski M, et al. ((2009)) Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer. J Physiol Pharmacol 60 (Suppl 4): 63--70.
36. Anand N, Murthy S, Amann G, Wernick M, Porter LA, et al. ((2002)) Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 31:: 301--305.
37. Pinke DE, Kalloger SE, Francetic T, Huntsman DG, Lee JM, ((2008)) The prognostic significance of elongation factor eEF1A2 in ovarian cancer. Gynecol Oncol 108:: 561--568.
38. Kulkarni G, Turbin DA, Amiri A, Jeganathan S, Andrade-Navarro MA, et al. ((2007)) Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer. Breast Cancer Res Treat 102:: 31--41.
39. Aubele M, Auer G, Walch AK, Munro A, Atkinson MJ, et al. ((2007)) PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. Br J Cancer 96:: 801--807.
40. Moniz S, Jordan P, ((2010)) Emerging roles for WNK kinases in cancer. Cell Mol Life Sci 67:: 1265--1276.
41. Hodgson JG, Chin K, Collins C, Gray JW, ((2003)) Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78:: 337--345.
42. Darsigny M, Babeu JP, Seidman EG, Gendron FP, Levy E, et al. ((2010)) Hepatocyte nuclear factor-4alpha promotes gut neoplasia in mice and protects against the production of reactive oxygen species. Cancer Res 70:: 9423--9433.
43. Sabbah M, Prunier C, Ferrand N, Megalophonos V, Lambein K, et al. ((2011)) CCN5, a novel transcriptional repressor of the transforming growth factor beta signaling pathway. Mol Cell Biol 31:: 1459--1469.
44. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, et al. ((2008)) Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15:: 1530--1537.
45. Aust DE, Muders M, Kohler A, Schmidt M, Diebold J, et al. ((2004)) Prognostic relevance of 20 q13 gains in sporadic colorectal cancers: a FISH analysis. Scand J Gastroenterol 39:: 766--772.
46. Andersen CL, Lamy P, Thorsen K, Kjeldsen E, Wikman F, et al. ((2010)) Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer.